Last week, NPR’s "All Things Considered" covered an unusual topic: Scientific conference posters. For the first time in decades, scientists are rethinking the traditional design of the posters they ...

Every month, scientists gather at conferences around the world. The topics range from climate change to big data to microorganisms and their role in plant, animal, and human health, but they are ...

LOS ANGELES--(BUSINESS WIRE)--Herbalife, a premier health and wellness company, announced today that members of its scientific and regulatory teams from around the world have been invited to present ...

Gaddikeri S, Vattoth S, DeHoff III GW, Smith CB, Combs JT, Roberson GR. Rathke Cleft Cysts: MR criteria for presumptive diagnosis. American Society of Neuroradiology ...

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its ...

CORAL GABLES, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel ...

The process through which research presented at scientific meetings is ultimately published in peer‐reviewed journals has become an important indicator of both scientific rigour and the potential ...

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...

LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative ...